Mitsubishi UFJ Asset Management Co., Ltd.
Position in HIMS — Hims & Hers Health, Inc.
CIK 1466546
TOKYO, M0
Position in HIMS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,067,297
+$3,575,276 QoQ
Shares Held
146,158
+103.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#100
of 504 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $198,678,635 across 14 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,070,271 | $76,909,674 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,372,243 | $46,491,592 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
47,346 | $25,653,483 | |
| 4 | VTRS |
Viatris Inc
|
1,443,227 | $22,918,444 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
111,484 | $18,789,513 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
146,158 | $5,067,297 | |
| 7 | LQDA |
Liquidia Corp
|
18,949 | $1,510,803 | |
| 8 | ALKS |
Alkermes plc.
|
20,588 | $1,078,811 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,067,297 | 146,158 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,492,021 | 71,870 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,258,732 | 38,766 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,884,522 | 33,225 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,121,815 | 42,564 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,663,871 | 56,307 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,230,931 | 50,907 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||